1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries

Corrado Tamburino, Piera Capranzano, Tommaso Gori, Azeem Latib, MacIej Lesiak, Holger Nef, Giuseppe Caramanno, Christopher Naber, Julinda Mehilli, Carlo Di Mario, Manel Sabaté, Thomas Münzel, Antonio Colombo, Aleksander Araszkiewicz, Jens Wiebe, Salvatore Geraci, Christoph Jensen, Alessio Mattesini, Salvatore Brugaletta, Davide Capodanno

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of '1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries'. Together they form a unique fingerprint.

Medicine & Life Sciences